Differential effects of smoking and COPD upon circulating myeloid derived suppressor cells

Respiratory Medicine

Volumn 107, Issue 12, 2013, Pages 1895-1903

  Scrimini, Sergio ^a,b   Pons, Jaume ^a,b   Agustí, Alvar ^a,b,c   Soriano, Joan B ^d   Cosio, Borja G ^a,b   Torrecilla, Juan A ^a   Núñez, Belén ^a,b   Córdova, Rocío ^a   Iglesias, Amanda ^a,b   Jahn, Andreas ^a,b   Crespi, Catalina ^a   Sauleda, Jaume ^a,b  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d Laboratory of Microbial Pathogenesis   (Spain)

Author keywords

Arginase I; Chronic inflammation; Myeloid cells; T cell receptor chain

Indexed keywords

ARGINASE 1; CD11B ANTIGEN; CD33 ANTIGEN; HLA DR ANTIGEN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ZETA CHAIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE MARROW CELL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MYELOID DERIVED SUPPRESSOR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SMOKING; SPIROMETRY; SUPPRESSOR CELL; UPREGULATION;

ARG I; ARGINASE I; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; COPD; MDSCS; MYELOID CELLS; MYELOID DERIVED SUPPRESSOR CELLS; PBMCS; PERIPHERAL BLOOD MONONUCLEAR CELLS; T-CELL RECEPTOR Ζ CHAIN; TCR Ζ;

ARGINASE; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNITY, CELLULAR; MALE; MIDDLE AGED; MYELOID CELLS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SMOKING; UP-REGULATION; VITAL CAPACITY;

EID: 84890313690     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.08.002     Document Type: Article

References (39)

1. J. Vestbo, S.S. Hurd, and A.G. Agusti Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, GOLD Executive Summary Am J Respir Crit Care Med 187 4 2013 347 365
2. J.C. Hogg, F. Chu, and S. Utokaparch The nature of small-airway obstruction in chronic obstructive pulmonary disease N Engl J Med 350 26 2004 2645 2653
3. M.G. Cosio, M. Saetta, and A. Agusti Immunologic aspects of chronic obstructive pulmonary disease N Engl J Med 360 23 2009 2445 2454
4. S.D. Shapiro End-stage chronic obstructive pulmonary disease: the cigarette is burned out but inflammation rages on Am J Respir Crit Care Med 164 3 2001 339 340
5. S.H. Lee, S. Goswami, and A. Grudo Antielastin autoimmunity in tobacco smoking-induced emphysema Nat Med 13 5 2007 567 569
6. B. Barceló, J. Pons, and J.M. Ferrer Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking Eur Respir J 31 3 2008 555 562
7. L.J. Smyth, C. Starkey, and J. Vestbo CD4-regulatory cells in COPD patients Chest 132 1 2007 156 163
8. J. Pons, J. Sauleda, and J.M. Ferrer Blunted gamma delta T-lymphocyte response in chronic obstructive pulmonary disease Eur Respir J 25 3 2005 441 446
9. S. Sakaguchi, T. Yamaguchi, and T. Nomura Regulatory T cells and immune tolerance Cell 133 5 2008 775 787
10. M. Girardi Immunosurveillance and immunoregulation by gammadelta T cells J Invest Dermatol 126 1 2006 25 31
11. D.I. Gabrilovich, and S. Nagaraj Myeloid-derived suppressor cells as regulators of the immune system Nat Rev Immunol 9 3 2009 162 174
12. V. Bronte, and P. Zanovello Regulation of immune responses by L-arginine metabolism Nature Rev Immunol 5 8 2005 641 654
13. P.C. Rodriguez, and A.C. Ochoa Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives Immunol Rev 222 2008 180 191
14. P.C. Rodriguez, M.S. Ernstoff, and C. Hernandez Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes Cancer Res 69 4 2009 1553 1560
15. G.A. Rabinovich, D. Gabrilovich, and E.M. Sotomayor Immunosuppressive strategies that are mediated by tumor cells Annu Rev Immunol 25 2007 267 296
16. J.G. Cripps, and J.D. Gorham MDSC in autoimmunity Int Immunopharmacol 11 7 2011 789 793
17. I. Poschke, and R. Kiessling On the armament and appearances of human myeloid-derived suppressor cells Clinical Immunology 144 3 2012 250 268
18. R.F. Gabitass, N.E. Annels, and D.D. Stocken Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13 Cancer Immunol Immunother 60 10 2011 1419 1430
19. Global Strategy for the Diagnosis, Management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available from: http://www.goldcopd.org/ [last accessed June 2012].
20. M.R. Miller, J. Hankinson, and V. Brusasco ATS/ERS Task Force. Standardisation of spirometry Eur Respir J 26 2 2005 319 338
21. J. Roca, J. Sanchis, and A. Agustí-Vidal Spirometric reference values for a Mediterranean population Bull Eur Physiopathol Respir 22 3 1986 217 224
22. C.M. Diaz-Montero, M.L. Salem, and M.I. Nishimura Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy Cancer Immunol Immunother 58 1 2009 49 59
23. I. Marigo, L. Dolcetti, and P. Serafini Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells Immunol Rev 222 2008 162 179
24. L.A. Haile, R. von Wasielewski, and J. Gamrekelashvili Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway Gastroenterology 135 3 2008 871 881
25. B. Yin, G. Ma, and C.Y. Yen Myeloid-derived suppressor cells prevent type 1 diabetes in murine models J Immunol 185 10 2010 5828 5834
26. J.R. Lees, A.M. Azimzadeh, and J.S. Bromberg Myeloid derived suppressor cells in transplantation Curr Opin Immunol 23 5 2011 692 697
27. M.E. Yeager, C.M. Nguyen, and D.D. Belchenko Circulating myeloid-derived suppressor cells are increased and activated in pulmonary hypertension Chest 141 4 2012 944 952
28. N. Rieber, A. Brand, and A. Hector Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease J Immunol 190 3 2013 1276 1284
29. M.T.C.R. Baniyash zeta-chain downregulation: curtailing an excessive inflammatory immune response Nat Rev Immunol 4 9 2004 675 687
30. U. Seitzer, K. Kayser, and H. Höhn Reduced T-cell receptor CD3zeta-chain protein and sustained CD3epsilon expression at the site of mycobacterial infection Immunology 104 3 2001 269 277
31. C.Y. Liu, Y.M. Wang, and C.L. Wang Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14-/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer J Cancer Res Clin Oncol 136 1 2010 35 45
32. A.H. Zea, P.C. Rodriguez, and M.B. Atkins Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion Cancer Res 65 8 2005 3044 3048
33. J. Schmielau, and O.J. Finn Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients Cancer Res 61 12 2001 4756 4760
34. J. Schmielau, M.A. Nalesnik, and O.J. Finn Suppressed T-cell receptor ζ chain expression and cytokine production in pancreatic cancer patients Clin Cancer Res 7 Suppl. 2001 933 939
35. A.V. Ezernitchi, I. Vaknin, and L. Cohen-Daniel TCR ζ down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs J Immunol 177 7 2006 4763 4772
36. N. Bronstein-Sitton, L. Cohen-Daniel, and I. Vaknin Sustained exposure to bacterial antigen induces interferon-γ-dependent T cell receptor ζ down-regulation and impaired T cell function Nat Immunol 4 10 2003 957 964
37. E. Reyes, A. Prieto, and A. de la Hera Treatment with AM3 restores defective T-cell function in COPD patients Chest 129 3 2006 527 535
38. W.Q. Gan, S.F. Man, and A. Senthilselvan Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis Thorax 59 7 2004 574 580
39. A. Agustí, L.D. Edwards, and S.I. Rennard Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype PLoS One 7 2012 e37483